ArticleInternational urology and nephrology2026
Impact of base excess on mortality in patients with sepsis-associated acute kidney injury: insights from US Intensive Care Unit Cohort.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Combined lactate, base excess, and MEWS score as predictors of ICU transfer from the emergency department: a retrospective cohort study.Frontiers in medicine · 2026Article
- Prognostic value of lactate-to-hemoglobin ratio in nontraumatic critically ill patients presenting to the emergency department: a retrospective cohort study.BMC emergency medicine · 2025Observational
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
6 authors.
Funding
Abstract
backgroundSepsis often leads to acute organ dysfunction and significantly increases the risk of mortality, frequently occurring alongside acute kidney injury, termed sepsis-associated acute kidney injury (Sa-AKI). This study aimed to assess whether base excess (BE) is associated with mortality in Sa-AKI patients within the intensive care unit (ICU).
methodsData were extracted from a US ICU cohort. BE served as the exposure variable, and 30-day and 90-day ICU all-cause mortality were the outcomes of interest. Multivariate Cox proportional hazards models were performed to assess the associations of BE and mortality outcomes of interest among Sa-AKI patients. Furthermore, multivariate restricted cubic spline (RCS) analyses were used to investigate potential nonlinear relationships between BE and outcomes of interest.
result10,812 Sa-AKI patients were included, RCS analyses demonstrated a non-linear relationship between BE and the risk of mortality for both 30-day and 90-day ICU mortality. Multivariate Cox proportional hazards models indicated that higher BE groups had a decreased risk of 30-day (Q3: HR 0.79, 95%CI 0.69-0.91; Q4: HR 0.82, 95%CI 0.73-0.93), 90-day ICU all-cause mortality (Q3: HR 0.81, 95%CI 0.72-0.91; Q4: HR 0.84, 95%CI 0.75-0.94) compared with the lowest BE group. Based on RCS analysis, patients were regrouped by BE values (Group 1: ≤ - 4 mmol/L, Group 2: - 4 to 7 mmol/L, Group 3: ≥ 7 mmol/L) for Kaplan-Meier survival analysis. Group 2 had the lowest 30-day and 90-day ICU mortality rate (log-rank P < 0.0001).
conclusionIn ICU patients with Sa-AKI, there is a non-linear relationship between BE levels and 30-day and 90-day all-cause mortality. A moderate BE range (- 4 to 7 mmol/L) is associated with a protective effect, whereas both excessively high and low BE levels increase mortality risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.